Benzoxazinone derivatives acting as beta2-adrenoreceptor agonist for the treatment of respiratory disorders

Details for Australian Patent Application No. 2009260899 (hide)

Owner AstraZeneca AB

Inventors Connolly, Stephen; Cook, Anthony Ronald; Bonnert, Roger Victor; Raubo, Piotr; Evans, Richard

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2009260899

PCT Pub. Number WO2009/154557

Priority 61/073,420 18.06.08 US

Filing date 17 June 2009

Wipo publication date 23 December 2009

Acceptance publication date 23 February 2012

International Classifications

C07D 413/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

A61K 31/538 (2006.01)

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

C07D 231/12 (2006.01) Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings

Event Publications

23 December 2010 PCT application entered the National Phase

  PCT publication WO2009/154557 Priority application(s): WO2009/154557

23 February 2012 Application Accepted

  Published as AU-B-2009260899

21 June 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009260904-Pharmaceutical composition comprising a 4-hydroxy-2-oxo-2, 3dihydro-1, 3-benzothiazol-7-yl compound for modulation of beta2-adrenoreceptor activity

2009260888-Compositions for linking DNA-binding domains and cleavage domains